Skip to content

Postoperative pain relief and analgesia after laproscopic cholecystectomy: bupivacaine versus nalbuphine ,when instilled through the laprpscopic port

Postoperative pain relief after laproscopic cholecystectomy: intraperitoneal bupivacaine versus nalbuphine

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/028869
Enrollment
80
Registered
2020-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration Health Condition 2: K800- Calculus of gallbladder with acutecholecystitis

Interventions

Intervention1: nalbuphine: nalbuphine 10 mg to be instilled intraperitoneally Control Intervention1: bupivacaine: bupivacaine 0.5% 20 ml instilled intraperitoneally

Sponsors

Hakeem Abdul Centenary hospitalNew Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Eighty patients ( 40 in each group) with ASA 1,2, aged 18-60 years, undergoing laproscopic cholecystectomy were be included in the study.

Exclusion criteria

Exclusion criteria: Patients with H/o chronic opioid intake Known allergy to local anaesthetics, Obese or pregnant patients were excluded from the study. Patients those who have chronic pain diseases (not related to choleystitis) or have acute cholecystitis before the surgery were also be excluded When the duration of surgery exceeded 2 hrs or if the surgery got converted to open, were also excluded.

Design outcomes

Primary

MeasureTime frame
to compare and assess the VAS score at different intervals and to determine the time of first analgesic request.Timepoint: post operative ,2 ,4 ,6 hrs upto 24 hrs

Secondary

MeasureTime frame
to compare the analgesic request rate ( number of doses of tramadol in 24 hrs), patient satisfaction score , incidence of shoulder pain and time to return to normal activity.Timepoint: uptl 24 hrs

Countries

India

Contacts

Public ContactSAMIKSHA KHANUJA

Hamdard Institute Of Medical Sciences,New Delhi

ssajr123@yahoo.com702397398

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026